Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | -9.09% | +3.09% | -9.09% |
22/04 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
22/04 | PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 339M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+47.07% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics' : Second Drug Candidate for ADOA to Start Human Trials in 2023; Shares Fall 3%